Robert Geho
Tracked across 1 events · 12 articles · First seen May 26, 2026 · Last active Jun 05, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Robert Geho, CEO of Diasome Pharmaceuticals, expressed optimism about the potential of HDV-Insulin Lispro to improve diabetes management.
May 26, 2026 · 12 articles
ERGEN INTELLIGENCE
Track Robert Geho live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard